Report Highlights
Here are the key highlights from the report:
- Feed Scope: Companies developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of ear, nose and throat (ENT) diseases
Companies included in the report
Companies developing medical devices, diagnostics tests, and pharmaceuticals for the diagnosis and treatment of ear, nose and throat (ENT) diseasesTop ENT Disorders Companies
The top 3 companies in ENT Disorders are Cochlear, Advanced Bionics and Starkey.Recent Investments
Recent noteworthy Investments in ENT Disorders sector include:- $74.3M, Series C round in NeuroMark Genomics on Feb 12, 2026
- $27.1M, Series B round in Spiral Therapeutics on Sep 30, 2025
- $24.7M, Series B round in Spirair on Jul 28, 2025
Report Preview
__sxX6OQfMKKye0E401PAVB.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__WrsbZAaRnpqAS8Q2jYQWm.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__QtAYU-3uBemC06GqjK_r5.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
__wB7qqhssHmRdvJoaXs2Q7.jpg?format=webp&quality=100&width=1043&devicePixelRatio=3)
